Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients.
暂无分享,去创建一个
S. Sela | R. Farah | R. Shurtz-Swirski | B. Kristal | G. Shapiro | R. Mazor | Meital Cohen-Mazor | E. Meilin | F. Dorlechter | S. Tamara
[1] N. Vaziri,et al. Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease. , 2007, Kidney international.
[2] S. Sela,et al. [Polymorphonuclear leukocyte priming and counts are in correlation with blood pressure parameters]. , 2006, Harefuah.
[3] S. Sela,et al. Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.
[4] E. Sato,et al. Enhanced oxidative stress in neutrophils from hyperlipidemic guinea pig. , 2005, Atherosclerosis.
[5] T. Imaizumi,et al. Polymorphonuclear Leukocytes May Impair Endothelial Function: Results of Crossover Randomized Study of Lipid-Lowering Therapies , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[6] A. Lumsden,et al. Defensins and cathelicidins: Neutrophil peptides with roles in inflammation, hyperlipidemia and atherosclerosis , 2005, Journal of cellular and molecular medicine.
[7] P. Stenvinkel,et al. Inflammation and oxidative stress in ESRD--the role of myeloperoxidase. , 2004, Journal of nephrology.
[8] L. Kosmiski,et al. Acute Pancreatitis in HIV-Infected Patients: Are Etiologies Changing Since the Introduction of Protease Inhibitor Therapy? , 2003, Pancreas.
[9] P. Stenvinkel,et al. A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients. , 2003, Kidney international. Supplement.
[10] N. Hollenberg,et al. Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus. , 2003, Kidney international.
[11] J. Wetzels,et al. Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] S. Sela,et al. The involvement of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation among cigarette smokers. , 2002, The Israel Medical Association journal : IMAJ.
[13] M. Rosenfeld,et al. Chlamydia pneumoniae and Hyperlipidemia Are Co-Risk Factors for Atherosclerosis: Infection Prior to Induction of Hyperlipidemia Does Not Accelerate Development of Atherosclerotic Lesions in C57BL/6J Mice , 2002, Infection and Immunity.
[14] T. Rohn,et al. Neutrophil priming in host defense: role of oxidants as priming agents. , 2002, Antioxidants & redox signaling.
[15] E J Topol,et al. Association between myeloperoxidase levels and risk of coronary artery disease. , 2001, JAMA.
[16] K. Chien,et al. Peripheral differential leukocyte counts in humans vary with hyperlipidemia, smoking, and body mass index , 2001, Lipids.
[17] S. Sela,et al. Involvement of Peripheral Polymorphonuclear Leukocytes in Oxidative Stress and Inflammation in Type 2 Diabetic Patients , 2001 .
[18] A. Carr,et al. Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[19] E. Bey,et al. In vitro knockout of human p47phox blocks superoxide anion production and LDL oxidation by activated human monocytes. , 2000, Journal of lipid research.
[20] S. Sela,et al. Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension. , 1997, American journal of hypertension.
[21] D. Discher,et al. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. , 1996, Blood.
[22] R. Maranhão,et al. Evaluation of oxidative stress in patients with hyperlipidemia. , 1995, Atherosclerosis.
[23] L. Mcphail,et al. Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme , 1984, The Journal of experimental medicine.
[24] D. Hunninghake,et al. INCREASED LEUCOCYTE OXIDATIVE METABOLISM IN HYPERLIPOPROTEINAEMIA , 1982, The Lancet.
[25] C. McCall,et al. Human toxic neutrophils. 3. Metabolic characteristics. , 1973, The Journal of infectious diseases.
[26] V. Faber,et al. THE TOXICITY OF CADMIUM , 1964, Lancet.